ABI-1968 topical cream / Antiva Biosci - LARVOL DELTA

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. (clinicaltrials.gov) - P1; N=8; Completed; Sponsor: Antiva Biosciences; Recruiting ➔ Completed; N=24 ➔ 8

Clinical • Enrollment change • Trial completion • Cervical Cancer • Gynecology • Human Immunodeficiency Virus • Infectious Disease • Oncology • Solid Tumor

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (clinicaltrials.gov) - P1; N=6; Terminated; Sponsor: Antiva Biosciences; N=18 ➔ 6; Active, not recruiting ➔ Terminated; Pre-Clinical Toxicology Findings

Clinical • Enrollment change • Trial termination

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. (clinicaltrials.gov) - P1; N=24; Recruiting; Sponsor: Antiva Biosciences; Trial completion date: Jul 2019 ➔ Aug 2020; Trial primary completion date: Jun 2019 ➔ Jun 2020

Clinical • Trial completion date • Trial primary completion date